Kabra Drugs Limited (BOM:524322)
India
· Delayed Price · Currency is INR 24.91
+0.14 (0.57%)
At close: Apr 28, 2026
Kabra Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 212.99 | 26.71 | 0.03 | 0.01 | 0.1 | Upgrade
|
| Short-Term Investments | - | 0.44 | 0.44 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 116.99 | 213.43 | 27.15 | 0.03 | 0.01 | 0.1 | Upgrade
|
| Cash Growth | 460.19% | 686.23% | 91932.82% | 133.67% | -87.10% | -10.75% | Upgrade
|
| Accounts Receivable | - | 6.01 | 6.01 | 6 | 6 | 12.55 | Upgrade
|
| Receivables | - | 6.01 | 6.01 | 6.44 | 6.72 | 13.26 | Upgrade
|
| Other Current Assets | - | 32.19 | 12.33 | 0.33 | 0.33 | 0.33 | Upgrade
|
| Total Current Assets | - | 251.62 | 45.48 | 6.8 | 7.06 | 13.69 | Upgrade
|
| Property, Plant & Equipment | - | 0.44 | - | - | - | 0.1 | Upgrade
|
| Other Long-Term Assets | - | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade
|
| Total Assets | - | 252.29 | 45.72 | 7.04 | 7.3 | 14.02 | Upgrade
|
| Accounts Payable | - | - | - | - | - | 1.87 | Upgrade
|
| Short-Term Debt | - | 4.37 | 17.09 | 13.82 | 10.26 | 9 | Upgrade
|
| Other Current Liabilities | - | 1.37 | 17.8 | 0.53 | 0.97 | 5.22 | Upgrade
|
| Total Current Liabilities | - | 5.74 | 34.89 | 14.35 | 11.23 | 16.1 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.01 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | -0 | 0 | 0 | - | Upgrade
|
| Total Liabilities | - | 5.74 | 34.89 | 14.35 | 11.23 | 16.1 | Upgrade
|
| Common Stock | - | 237.08 | 43.89 | 43.89 | 43.89 | 43.89 | Upgrade
|
| Retained Earnings | - | 9.47 | -58.56 | -51.2 | -47.82 | -45.96 | Upgrade
|
| Comprehensive Income & Other | - | -0 | 25.5 | - | - | - | Upgrade
|
| Shareholders' Equity | 259.92 | 246.55 | 10.83 | -7.31 | -3.93 | -2.08 | Upgrade
|
| Total Liabilities & Equity | - | 252.29 | 45.72 | 7.04 | 7.3 | 14.02 | Upgrade
|
| Total Debt | 4.69 | 4.37 | 17.09 | 13.82 | 10.26 | 9 | Upgrade
|
| Net Cash (Debt) | 112.29 | 209.06 | 10.06 | -13.79 | -10.25 | -8.91 | Upgrade
|
| Net Cash Growth | 675.46% | 1977.87% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 5.32 | 19.13 | 2.29 | -3.14 | -2.33 | -2.03 | Upgrade
|
| Filing Date Shares Outstanding | 23.76 | 23.71 | 4.39 | 4.39 | 4.39 | 4.39 | Upgrade
|
| Total Common Shares Outstanding | 23.76 | 23.71 | 4.39 | 4.39 | 4.39 | 4.39 | Upgrade
|
| Working Capital | - | 245.88 | 10.6 | -7.54 | -4.16 | -2.41 | Upgrade
|
| Book Value Per Share | 10.90 | 10.40 | 2.47 | -1.67 | -0.90 | -0.47 | Upgrade
|
| Tangible Book Value | 259.89 | 246.55 | 10.83 | -7.31 | -3.93 | -2.08 | Upgrade
|
| Tangible Book Value Per Share | 10.89 | 10.40 | 2.47 | -1.67 | -0.90 | -0.47 | Upgrade
|
| Machinery | - | 0.44 | - | 1.66 | 1.66 | 1.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.